Osimertinib
astrazeneca
['congrat', 'nsclc', 'sclc']
congrats to the audura investigators and patients. a genuinely impressive result confirming the transformative impact of genetically-tailored therapy in nsclc. what a long way the field has come from the days when "platinum doublets" were about all we had to offer. #asco23
Stanford Oncologist || BYU alum || Penn Med alum || author || American Studies amateur || religious studies amateur || podcasting @ https://t.co/KnVbI8oZ43